Fairvalue-Calculator Fairvalue-Calculator
EN DE

Guanhao Biotech Co (300238) Fair Value & Analysis

Healthcare · CN · Market cap 2.9B CNY

Price¥10.96
Fair Value¥2.02
Upside-81.6%
Quality83/100
Evidence: Medium Range ¥1.51 – ¥2.52

Fair value as of: Jun 24, 2026

Analysis

Guanhao Biotech Co (300238) currently trades at ¥10.96, while our model-based Fair Value estimate is ¥2.02 — implying the stock looks roughly 81.6% overvalued today. We read business quality at 83/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. It offers NormalGEN and GrandNeuro, both a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; Type B dura, a spinal patch; Sterile Bio Wound Membrane; Ario Mesh; Thoracic Surgery Repair Diaphragm; and Cympic Benvimod Cream for psoriasis. In addition, it offers artificial lens and medical instruments; and cell technology services. Its products can be used in neurosurgery, thoracic general surgery, ophthalmology, dermatology, orthopedics, cosmetology, plastic surgery, and other areas. Guanhao Biotech Co.,Ltd. was founded in 1999 and is headquartered in Guangzhou, China.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Guanhao Biotech Co (300238) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥2.02 versus a price of ¥10.96 — about −82% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 300238?
Our 21-model fair value for Guanhao Biotech Co is ¥2.02 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥10.96.
What is the quality score of 300238?
Guanhao Biotech Co has a Quality Score of 83/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.